Immunosuppressive treatment of nephrotic syndrome.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000686:Amyloidosis / Q000188:drug therapy; D001379:Azathioprine / Q000627:therapeutic use; D001706:Biopsy; D001798:Blood Proteins / Q000032:analysis; D002699:Chlorambucil / Q000627:therapeutic use; D003609:Dactinomycin / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007668:Kidney / Q000473:pathology; D008297:Male; D015122:Mercaptopurine / Q000627:therapeutic use; D008722:Methods; D008875:Middle Aged; D009404:Nephrotic Syndrome / Q000175:diagnosis / Q000188:drug therapy*; D011241:Prednisone / Q000627:therapeutic use; D011379:Prognosis
D001798:Blood Proteins; D007166:Immunosuppressive Agents; D002699:Chlorambucil; D003609:Dactinomycin; D015122:Mercaptopurine; D001379:Azathioprine; D011241:Prednisone